Literature DB >> 22710669

Kidney cancer: Metabolomics for targeted therapy.

Melanie Clyne.   

Abstract

Entities:  

Year:  2012        PMID： 22710669     DOI： 10.1038/nrurol.2012.127

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis.

Authors:  Sheila Ganti; Sandra L Taylor; Omran Abu Aboud; Joy Yang; Christopher Evans; Michael V Osier; Danny C Alexander; Kyoungmi Kim; Robert H Weiss
Journal:  Cancer Res       Date:  2012-05-24       Impact factor: 12.701
  1 in total
  2 in total

1.  Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.

Authors:  Geng Zhang; Peijun He; Hanson Tan; Anuradha Budhu; Jochen Gaedcke; B Michael Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Anirban Maitra; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  Clin Cancer Res       Date:  2013-08-05       Impact factor: 12.531

2.  Flow-Responsive Vascular Endothelial Growth Factor Receptor-Protein Kinase C Isoform Epsilon Signaling Mediates Glycolytic Metabolites for Vascular Repair.

Authors:  Kyung In Baek; Rongsong Li; Nelson Jen; Howard Choi; Amir Kaboodrangi; Peipei Ping; David Liem; Tyler Beebe; Tzung K Hsiai
Journal:  Antioxid Redox Signal       Date:  2017-09-21       Impact factor: 8.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.